Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2789 (LINC02789) is classified as a long intergenic non-coding RNA (lincRNA), which is a subclass of long non-coding RNAs defined by their location in genomic regions that do not overlap annotated protein-coding genes. LincRNAs generally exceed 200 nucleotides in length and are involved in diverse biological processes such as chromatin modification, transcriptional regulation, and RNA stabilization. While many lincRNAs are shown to have tissue-specific regulatory functions and can be implicated in development and disease, the specific biological function and disease relevance of LINC02789 remain uncharacterized in current literature and genomic databases. There is no evidence that LINC02789 serves as a direct therapeutic target or is involved as a biomarker in clinical settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2789 (LINC02789).